Related Experiment Videos

Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer

M E Boursnell¹, C Entwisle, S A Ali

¹Cantab Pharmaceuticals Research Ltd., Cambridge, United Kingdom.

Advances in Experimental Medicine and Biology

|February 23, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Construction and Use of Cell Lines Expressing HSV Genes.

Methods in molecular medicine·2011

Characterization of secreted and intracellular forms of a truncated hepatitis C virus E2 protein expressed by a recombinant herpes simplex virus.

The Journal of general virology·2003

Preclinical safety testing of DISC-hGMCSF to support phase I clinical trials in cancer patients.

The journal of gene medicine·2001

Induction of anti-mammary cancer immunity by engaging the OX-40 receptor in vivo.

Breast cancer research and treatment·2001

Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.

Cancer gene therapy·2000

Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.

Cancer research·2000

See all related articles